CN108025054B - 用于治疗和/或预防肿瘤的沙粒病毒和用于制备具有(改善的)肿瘤消退性能的沙粒病毒的方法 - Google Patents
用于治疗和/或预防肿瘤的沙粒病毒和用于制备具有(改善的)肿瘤消退性能的沙粒病毒的方法 Download PDFInfo
- Publication number
- CN108025054B CN108025054B CN201680030624.5A CN201680030624A CN108025054B CN 108025054 B CN108025054 B CN 108025054B CN 201680030624 A CN201680030624 A CN 201680030624A CN 108025054 B CN108025054 B CN 108025054B
- Authority
- CN
- China
- Prior art keywords
- tumor
- cancer
- cells
- arenavirus
- arenaviruses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
- C12N2760/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
- C12N2760/10032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
- C12N2760/10033—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102015207036.0 | 2015-04-17 | ||
| DE102015207036.0A DE102015207036A1 (de) | 2015-04-17 | 2015-04-17 | Arenaviren zur Anwendung bei der Behandlung und/oder Vorbeugung von Tumoren sowie Verfahren zur Herstellung von Arenaviren mit (verbesserten) tumorregressiven Eigenschaften |
| PCT/EP2016/058347 WO2016166285A1 (de) | 2015-04-17 | 2016-04-15 | Arenaviren zur anwendung bei der behandlung und/oder vorbeugung von tumoren sowie verfahren zur herstellung von arenaviren mit (verbesserten) tumorregressiven eigenschaften |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108025054A CN108025054A (zh) | 2018-05-11 |
| CN108025054B true CN108025054B (zh) | 2022-12-23 |
Family
ID=55759589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201680030624.5A Active CN108025054B (zh) | 2015-04-17 | 2016-04-15 | 用于治疗和/或预防肿瘤的沙粒病毒和用于制备具有(改善的)肿瘤消退性能的沙粒病毒的方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20180117137A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3283104B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7039037B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN108025054B (cg-RX-API-DMAC7.html) |
| CA (1) | CA2982873A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE102015207036A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3017684T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016166285A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2811093T3 (es) | 2014-11-13 | 2021-03-10 | Univ Geneve | Arenavirus trisegmentados como vectores de vacunas |
| DE102015207036A1 (de) | 2015-04-17 | 2016-10-20 | Karl Sebastian Lang | Arenaviren zur Anwendung bei der Behandlung und/oder Vorbeugung von Tumoren sowie Verfahren zur Herstellung von Arenaviren mit (verbesserten) tumorregressiven Eigenschaften |
| HK1246183A1 (zh) | 2015-06-10 | 2018-09-07 | Hookipa Biotech Gmbh | Hpv疫苗 |
| WO2017076988A1 (en) | 2015-11-04 | 2017-05-11 | Hookipa Biotech Ag | Vaccines against hepatitis b virus |
| EP3373959B1 (en) | 2015-11-12 | 2022-06-29 | Hookipa Biotech GmbH | Arenavirus particles as cancer vaccines |
| CN110719788A (zh) * | 2017-04-07 | 2020-01-21 | 霍欧奇帕生物科技有限公司 | 治疗实体瘤的沙粒病毒颗粒 |
| DE102018215551A1 (de) * | 2018-09-12 | 2020-03-12 | Virolutions Biotech Gmbh | Verfahren zur Herstellung eines antitumoralen Arenavirus sowie Arenavirusmutanten |
| WO2022180203A1 (en) | 2021-02-26 | 2022-09-01 | Abalos Therapeutics Gmbh | New virus particles for therapeutic purposes |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004034461B4 (de) | 2004-07-16 | 2008-02-07 | Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus | Gentherapie solider Tumore durch retrovirale, mit Arenavirus-Glykoprotein pseudotypisierte Vektoren |
| US7994221B2 (en) * | 2004-12-06 | 2011-08-09 | Siga Technologies, Inc. | Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses |
| CN103993012B (zh) | 2007-12-27 | 2023-01-10 | 苏黎士大学 | 复制缺陷型沙粒病毒载体 |
| WO2011056993A1 (en) * | 2009-11-04 | 2011-05-12 | Yale University | Compositions and methods for treating cancer with attenuated oncolytic viruses |
| DE102015207036A1 (de) | 2015-04-17 | 2016-10-20 | Karl Sebastian Lang | Arenaviren zur Anwendung bei der Behandlung und/oder Vorbeugung von Tumoren sowie Verfahren zur Herstellung von Arenaviren mit (verbesserten) tumorregressiven Eigenschaften |
-
2015
- 2015-04-17 DE DE102015207036.0A patent/DE102015207036A1/de active Pending
-
2016
- 2016-04-15 WO PCT/EP2016/058347 patent/WO2016166285A1/de not_active Ceased
- 2016-04-15 CN CN201680030624.5A patent/CN108025054B/zh active Active
- 2016-04-15 ES ES16717129T patent/ES3017684T3/es active Active
- 2016-04-15 EP EP16717129.7A patent/EP3283104B1/de active Active
- 2016-04-15 JP JP2018505536A patent/JP7039037B2/ja active Active
- 2016-04-15 US US15/567,343 patent/US20180117137A1/en not_active Abandoned
- 2016-04-15 CA CA2982873A patent/CA2982873A1/en active Pending
-
2019
- 2019-02-04 US US16/267,095 patent/US11801294B2/en active Active
-
2021
- 2021-05-27 JP JP2021088871A patent/JP7273102B2/ja active Active
-
2023
- 2023-10-30 US US18/385,250 patent/US12409217B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3283104A1 (de) | 2018-02-21 |
| BR112017022022A8 (pt) | 2023-03-07 |
| JP7039037B2 (ja) | 2022-03-22 |
| JP7273102B2 (ja) | 2023-05-12 |
| CN108025054A (zh) | 2018-05-11 |
| JP2021129589A (ja) | 2021-09-09 |
| CA2982873A1 (en) | 2016-10-20 |
| US11801294B2 (en) | 2023-10-31 |
| US20190151436A1 (en) | 2019-05-23 |
| WO2016166285A1 (de) | 2016-10-20 |
| ES3017684T3 (en) | 2025-05-13 |
| DE102015207036A1 (de) | 2016-10-20 |
| HK1251168A1 (zh) | 2019-01-25 |
| JP2018515130A (ja) | 2018-06-14 |
| EP3283104C0 (de) | 2024-12-11 |
| US12409217B2 (en) | 2025-09-09 |
| US20240252611A1 (en) | 2024-08-01 |
| BR112017022022A2 (pt) | 2019-01-22 |
| US20180117137A1 (en) | 2018-05-03 |
| EP3283104B1 (de) | 2024-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12409217B2 (en) | Administering a lymphocytic choriomeningtitis virus (LCMV) with improved tumor regression properties | |
| JP6794442B2 (ja) | 新規な遺伝子組換えワクシニアウイルス | |
| CN102174479B (zh) | 靶向性治疗人肿瘤的溶肿瘤腺病毒及其应用 | |
| CN108307642B (zh) | 改造的白介素12及其在制备治疗肿瘤药物中的用途 | |
| CN115397838A (zh) | 溶瘤病毒样囊泡的组合物和使用方法 | |
| US20250122244A1 (en) | Method for producing an antitumoral arenavirus as well as arenavirus mutants | |
| EP2826856B9 (en) | Genetically stable oncolytic RNA virus, method of manufacturing and use thereof | |
| CN115804853A (zh) | 包含rna分子的组合物及其在制备瘤内注射剂中的用途 | |
| CN115702940A (zh) | 包含环状rna分子的制剂在制备治疗肿瘤的药物中的应用 | |
| BR112017022022B1 (pt) | Uso de um vírus da coriomeningite linfocítica (lcmv) ou um vírus junin e composição compreende os mesmos | |
| HK1251168B (en) | Arenavirus for use in treatment of tumors in human | |
| HK40122461A (en) | Method for producing an antitumoral arenavirus as well as arenavirus mutants | |
| WO2025234450A1 (ja) | 改変がん細胞及びそれを含むがんワクチン組成物 | |
| CN118256561A (zh) | 靶向双激酶aurka/cdk7的疫苗在治疗实体瘤中的应用 | |
| HK40054624A (en) | Method for producing an antitumoral arenavirus as well as arenavirus mutants | |
| CN120173884A (zh) | 功能优化的嵌合抗原受体效应细胞及其在制备治疗急性髓系白血病的组合物中的应用 | |
| HK40054624B (en) | Method for producing an antitumoral arenavirus as well as arenavirus mutants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20191030 Address after: Essen, Germany Applicant after: Vinolusence Biotechnology Co.,Ltd. Address before: Essen, Germany Applicant before: Karl Sebastan Lan |
|
| CB02 | Change of applicant information | ||
| CB02 | Change of applicant information |
Address after: essen Applicant after: Abalos treatment Ltd. Address before: essen Applicant before: Vinolusence Biotechnology Co.,Ltd. |
|
| CB02 | Change of applicant information | ||
| CB02 | Change of applicant information |
Address after: Dusseldorf Applicant after: Abalos treatment Ltd. Address before: essen Applicant before: Abalos treatment Ltd. |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant |